PeÑaranda, Cristopher .

HRN: 29-48-68  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/16/2026
CEFTRIAXONE 1G (VIAL)
08/16/2026
08/23/2026
IV
1 Gm
Q12h
Galeazzi Fracture-Dislocation, Right
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Bone & JointSkin & Soft Tissue    Compliance to guidelines: